CRISPR Therapeutics AG (CRSP) vs RadNet, Inc. (RDNT)
A side-by-side comparison of CRISPR Therapeutics AG and RadNet, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CRSP
CRISPR Therapeutics AG
$54.59HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
RDNT
RadNet, Inc.
$70.38HealthcareDelayed quote: Oct 6, 2026, 2:19 PM EDT
Total return — CRSP vs RDNT
growth of $100 · dividends reinvested · last 10yCRSP +307.0% (+15.1%/yr)RDNT +844.7% (+25.2%/yr)RDNT compounded faster over this window
CRSP RDNT
CRSP vs RDNT: by the numbers
- •RDNT is the larger company ($5.53B vs $5.27B market cap).
- •Both run net losses; RDNT's is the smaller (-0.93% vs -3368.72% net margin).
- •CRSP grew revenue faster over the past five years (37.32% vs 12.68% CAGR).
Metrics side by side
Valuation
| Metric | CRSP | RDNT |
|---|---|---|
| Forward P/E | N/A | 136.86 |
| P/S ratio | 393.16 | 2.44 |
| P/B ratio | 3.01 | 5.05 |
| EV / EBITDA | N/A | 21.72 |
Profitability
| Metric | CRSP | RDNT |
|---|---|---|
| Gross margin | -6537.01% | 9.70% |
| Operating margin | -16191.40% | 4.00% |
| Net margin | -3368.72% | -0.93% |
| ROE | -25.83% | -1.93% |
| ROIC | -21.12% | 1.41% |
Growth (annualized)
| Metric | CRSP | RDNT |
|---|---|---|
| Revenue CAGR (5Y) | 37.32% | 12.68% |
| Total return CAGR (5Y) | -10.97% | 19.72% |
Frequently asked
- Which has grown faster, CRSP or RDNT?
- Over the past five years, CRSP grew revenue faster — CRSP at a 37.32% CAGR versus RDNT at 12.68%.
- How have CRSP and RDNT total returns compared?
- Over the past 5 years, CRSP delivered -10.97% and RDNT delivered 19.72% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
CRISPR Therapeutics AG ROERadNet ROECRISPR Therapeutics AG operating marginRadNet operating marginCRISPR Therapeutics AG revenue growthRadNet revenue growthCRISPR Therapeutics AG free cash flowRadNet free cash flow
CRISPR Therapeutics AG & RadNet appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.